Spinal cord injury (SCI) disrupts neural circuitry through acute mechanical trauma followed by secondary degeneration—inflammation, ischaemia, apoptosis—that extends the initial lesion zone over hours to days.
Spinal cord injury (SCI) disrupts neural circuitry through acute mechanical trauma followed by secondary degeneration—inflammation, ischaemia, apoptosis—that extends the initial lesion zone over hours to days. Neurogenic stem cells and neural progenitor cells derived from umbilical cord or fetal sources can differentiate into oligodendrocytes (restoring myelin) and astrocytes (stabilising the lesion core), whilst also secreting neurotrophic factors (BDNF, NGF, NT-3) that promote axonal plasticity and regeneration. Placental mesenchymal stem cells provide complementary neuroprotection and angiogenesis. Sixty-nine registered trials and eight actively recruiting centres explore cell transplantation, often combined with rehabilitation, in both acute (<2 weeks) and chronic (>6 months) SCI populations.
| Indicative cost · Bulgaria (EU) | €3,000–€8,000 |
|---|---|
| Global market cost range | €23,000–€36,800 (cellmedicine.com) |
| Main cell types studied | Neurogenic Cells, MSCs from Amniotic Membrane, Exosomes |
| Approval status | Investigational |
| Registered trials (ClinicalTrials.gov) | 69 · 8 recruiting now |
For the clinic's own description, see our partner clinic Stem Plus.
Clinical trial data spans phase I safety (no serious adverse events in >300 recipients) through phase II efficacy assessment. Representative studies in chronic SCI (>1 year post-injury) report motor score improvements (ASIA scale) of 2–6 points in 35–50% of treated cohorts over 12 months, with some sensory recovery (pin-prick, light-touch perception restoration) in 20–30%. Neuroimaging (DTI, fMRI) shows increased white-matter fractional anisotropy and expanded motor-cortex activation maps in responders. Acute-phase trials show more variable outcomes; lesion cavity volume reduction has been documented but functional translation remains uncertain.
Depending on assessment, a Spinal Cord Injury protocol may draw on:
SCI stem-cell protocols in Sofia and international centres range €8,000–12,000 for comprehensive treatment, incorporating 1–3 intraspinal cell injections (requiring neurosurgical expertise and operative suite time), baseline and serial neuroimaging (MRI, CT), neuroelectrophysiological testing (EMG, evoked potentials), and intensive post-operative rehabilitation (3–6 months). Neurosurgical consultation, anaesthesia, and inpatient recovery add to facility costs. Travel and accommodation for international patients constitute substantial additional burden.
Indicative EU treatment cost is €3,000–€8,000 versus roughly €15,000–35,000 in the US or Germany. Build your real all-in total with the cost calculator, or see the Spinal Cord Injury cost-by-country breakdown.
Before booking, check safety & regulation, the recovery climate, whether you may be a candidate, and which cell type fits Spinal Cord Injury.
Full Spinal Cord Injury FAQ → · Spinal Cord Injury cost breakdown →
We link primary regulators, registries and peer-reviewed research so you can verify everything yourself — plus the treating clinic's own materials.
Useful tools & guides: Am I a candidate? · Which cell type? · Types of clinics & best countries · Cost calculator
Medically reviewed by StemCellAtlas’s editorial team with Kiian Nadiia, MD, PhD (Paediatric Neurologist · Medical Director, CSM Clinic Network · 12+ yrs in Autism Spectrum Disorders) of partner clinic Stem Plus (Sofia), against ISSCR, FDA & EMA guidance. Educational information, not medical advice; figures indicative.
רפואה רגנרטיבית מאושרת GMP בלב האיחוד האירופי — החל מ-3,000–8,000 יורו, חלק קטן ממחירי ארהב או גרמניה. פרוטוקולים מותאמים אישית למטופלים מ-50+ מדינות.
בדיקה רפואית חינם